Adverse Events After Coronary Revascularization Procedures in California 2000 to 2010
Public reporting of coronary artery bypass grafting (CABG) mortality in California was initiated in 2003. Drug-eluting stents were widely introduced in the same year. Adverse events after percutaneous coronary intervention (PCI) and CABG were analyzed to study the impact of these events. Annual Cali...
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2013-08, Vol.112 (4), p.483-487 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 487 |
|---|---|
| container_issue | 4 |
| container_start_page | 483 |
| container_title | The American journal of cardiology |
| container_volume | 112 |
| creator | Rudersdorf, Patrick D., MD Abolhoda, Amir, MD Carey, Joseph S., MD Danielsen, Beate, PhD Milliken, Jeffrey C., MD |
| description | Public reporting of coronary artery bypass grafting (CABG) mortality in California was initiated in 2003. Drug-eluting stents were widely introduced in the same year. Adverse events after percutaneous coronary intervention (PCI) and CABG were analyzed to study the impact of these events. Annual California hospital discharge data were collected from 2000 through 2010. In-hospital mortality and hospital readmission for adverse events 6,000 adverse events by the end of the decade. |
| doi_str_mv | 10.1016/j.amjcard.2013.04.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1418144437</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000291491300982X</els_id><sourcerecordid>1418144437</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-dcea434865dad103bf3c9891356ba9f858b9ea4b3f6efd22c5938eecf81047833</originalsourceid><addsrcrecordid>eNqFkd-K1TAQh4Mo7nH1EZSCN960Zpq0TW6Uw2HdFRYU_-FdSJMJpPY0a9IeWJ_GZ_HJTDlHhb3xagh888vMN4Q8BVoBhfblUOn9YHS0VU2BVZRXlMp7ZAOikyVIYPfJhlJalxK4PCOPUhryE6BpH5KzmrWtaJnYkC9be8CYsLg44DSnYutmjMUuxDDpeFt8wINOZhl19D_07MNUvI_BoF0ipsJPv37u9OhdiJPXRZ3ziznkCvQxeeD0mPDJqZ6Tz28uPu2uyut3l2932-vScC7m0hrUnHHRNlZboKx3zEiRh2_aXksnGtHLTPTMtehsXZtGMoFonADKO8HYOXlxzL2J4fuCaVZ7nwyOo54wLEkBBwGcc9Zl9PkddAhLnPJ0K9V0ouNsDWyOlIkhpYhO3US_zyoUULWKV4M6iVereEW5yuJz37NT-tLv0f7t-mM6A6-PAGYdB49RJeNxyi59RDMrG_x_v3h1J8GMfvJGj9_wFtO_bVSqFVUf1-uvxweWu0X9lf0GY5Sqog</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1415787433</pqid></control><display><type>article</type><title>Adverse Events After Coronary Revascularization Procedures in California 2000 to 2010</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Rudersdorf, Patrick D., MD ; Abolhoda, Amir, MD ; Carey, Joseph S., MD ; Danielsen, Beate, PhD ; Milliken, Jeffrey C., MD</creator><creatorcontrib>Rudersdorf, Patrick D., MD ; Abolhoda, Amir, MD ; Carey, Joseph S., MD ; Danielsen, Beate, PhD ; Milliken, Jeffrey C., MD</creatorcontrib><description>Public reporting of coronary artery bypass grafting (CABG) mortality in California was initiated in 2003. Drug-eluting stents were widely introduced in the same year. Adverse events after percutaneous coronary intervention (PCI) and CABG were analyzed to study the impact of these events. Annual California hospital discharge data were collected from 2000 through 2010. In-hospital mortality and hospital readmission for adverse events <1 year were determined for patients undergoing isolated CABG, PCI for acute coronary syndrome (PCI-ACS), and all other PCIs (PCI-noACS). CABG volume peaked in 2000 and subsequently decreased by 58%; PCI volume peaked in 2005 and subsequently decreased by 20%. After 2003, in-hospital mortality and 1-year mortality for CABG decreased whereas mortality after PCI remained unchanged. Event rates for acute myocardial infarction and stroke varied little over the decade; acute myocardial infarction at 1 year was 2.5% to 2.8% (CABG), 4.5% to 5.4% (PCI-ACS), and 4.6% to 5.8% (PCI-noACS); stroke rate was 1.4% to 1.7% (CABG), 1.2% to 1.6% (PCI-ACS), and 1.0% to 1.2% (PCI-noACS). Reintervention for PCI decreased markedly, from 18.8% to 12.8% (PCI-ACS) and 22.5% to 13.3% (PCI-noACS). Multiple adverse cardiovascular and cerebral events rate at 1 year decreased from 10.8% to 9.4% (CABG), 26.5% to 21.2% (PCI-ACS), and 26.8% to 18.4% (PCI-noACS). Excluding reinterventions, multiple adverse cardiovascular and cerebral events rate at 1 year was 8.3% (CABG), 14.6% (PCI-ACS), and 10.1% (PCI-noACS) in 2010. In conclusion, the volume of coronary interventions in California decreased whereas adverse event rates decreased after the introduction of public reporting and drug-eluting stents. Lower procedure volume combined with improved outcomes resulted in an annual decrease of >6,000 adverse events by the end of the decade.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2013.04.009</identifier><identifier>PMID: 23668638</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; California - epidemiology ; Cardiovascular ; Cardiovascular disease ; Coronary Artery Bypass ; Coronary vessels ; Female ; Heart attacks ; Hospital Mortality ; Hospitals ; Humans ; Incidence ; Male ; Middle Aged ; Mortality ; Myocardial Revascularization ; Percutaneous Coronary Intervention ; Postoperative Complications - epidemiology ; Postoperative period ; Risk Factors ; Stents ; Treatment Outcome</subject><ispartof>The American journal of cardiology, 2013-08, Vol.112 (4), p.483-487</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 15, 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-dcea434865dad103bf3c9891356ba9f858b9ea4b3f6efd22c5938eecf81047833</citedby><cites>FETCH-LOGICAL-c448t-dcea434865dad103bf3c9891356ba9f858b9ea4b3f6efd22c5938eecf81047833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1415787433?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23668638$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rudersdorf, Patrick D., MD</creatorcontrib><creatorcontrib>Abolhoda, Amir, MD</creatorcontrib><creatorcontrib>Carey, Joseph S., MD</creatorcontrib><creatorcontrib>Danielsen, Beate, PhD</creatorcontrib><creatorcontrib>Milliken, Jeffrey C., MD</creatorcontrib><title>Adverse Events After Coronary Revascularization Procedures in California 2000 to 2010</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Public reporting of coronary artery bypass grafting (CABG) mortality in California was initiated in 2003. Drug-eluting stents were widely introduced in the same year. Adverse events after percutaneous coronary intervention (PCI) and CABG were analyzed to study the impact of these events. Annual California hospital discharge data were collected from 2000 through 2010. In-hospital mortality and hospital readmission for adverse events <1 year were determined for patients undergoing isolated CABG, PCI for acute coronary syndrome (PCI-ACS), and all other PCIs (PCI-noACS). CABG volume peaked in 2000 and subsequently decreased by 58%; PCI volume peaked in 2005 and subsequently decreased by 20%. After 2003, in-hospital mortality and 1-year mortality for CABG decreased whereas mortality after PCI remained unchanged. Event rates for acute myocardial infarction and stroke varied little over the decade; acute myocardial infarction at 1 year was 2.5% to 2.8% (CABG), 4.5% to 5.4% (PCI-ACS), and 4.6% to 5.8% (PCI-noACS); stroke rate was 1.4% to 1.7% (CABG), 1.2% to 1.6% (PCI-ACS), and 1.0% to 1.2% (PCI-noACS). Reintervention for PCI decreased markedly, from 18.8% to 12.8% (PCI-ACS) and 22.5% to 13.3% (PCI-noACS). Multiple adverse cardiovascular and cerebral events rate at 1 year decreased from 10.8% to 9.4% (CABG), 26.5% to 21.2% (PCI-ACS), and 26.8% to 18.4% (PCI-noACS). Excluding reinterventions, multiple adverse cardiovascular and cerebral events rate at 1 year was 8.3% (CABG), 14.6% (PCI-ACS), and 10.1% (PCI-noACS) in 2010. In conclusion, the volume of coronary interventions in California decreased whereas adverse event rates decreased after the introduction of public reporting and drug-eluting stents. Lower procedure volume combined with improved outcomes resulted in an annual decrease of >6,000 adverse events by the end of the decade.</description><subject>Adult</subject><subject>Aged</subject><subject>California - epidemiology</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Coronary Artery Bypass</subject><subject>Coronary vessels</subject><subject>Female</subject><subject>Heart attacks</subject><subject>Hospital Mortality</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Myocardial Revascularization</subject><subject>Percutaneous Coronary Intervention</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative period</subject><subject>Risk Factors</subject><subject>Stents</subject><subject>Treatment Outcome</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkd-K1TAQh4Mo7nH1EZSCN960Zpq0TW6Uw2HdFRYU_-FdSJMJpPY0a9IeWJ_GZ_HJTDlHhb3xagh888vMN4Q8BVoBhfblUOn9YHS0VU2BVZRXlMp7ZAOikyVIYPfJhlJalxK4PCOPUhryE6BpH5KzmrWtaJnYkC9be8CYsLg44DSnYutmjMUuxDDpeFt8wINOZhl19D_07MNUvI_BoF0ipsJPv37u9OhdiJPXRZ3ziznkCvQxeeD0mPDJqZ6Tz28uPu2uyut3l2932-vScC7m0hrUnHHRNlZboKx3zEiRh2_aXksnGtHLTPTMtehsXZtGMoFonADKO8HYOXlxzL2J4fuCaVZ7nwyOo54wLEkBBwGcc9Zl9PkddAhLnPJ0K9V0ouNsDWyOlIkhpYhO3US_zyoUULWKV4M6iVereEW5yuJz37NT-tLv0f7t-mM6A6-PAGYdB49RJeNxyi59RDMrG_x_v3h1J8GMfvJGj9_wFtO_bVSqFVUf1-uvxweWu0X9lf0GY5Sqog</recordid><startdate>20130815</startdate><enddate>20130815</enddate><creator>Rudersdorf, Patrick D., MD</creator><creator>Abolhoda, Amir, MD</creator><creator>Carey, Joseph S., MD</creator><creator>Danielsen, Beate, PhD</creator><creator>Milliken, Jeffrey C., MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20130815</creationdate><title>Adverse Events After Coronary Revascularization Procedures in California 2000 to 2010</title><author>Rudersdorf, Patrick D., MD ; Abolhoda, Amir, MD ; Carey, Joseph S., MD ; Danielsen, Beate, PhD ; Milliken, Jeffrey C., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-dcea434865dad103bf3c9891356ba9f858b9ea4b3f6efd22c5938eecf81047833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>California - epidemiology</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Coronary Artery Bypass</topic><topic>Coronary vessels</topic><topic>Female</topic><topic>Heart attacks</topic><topic>Hospital Mortality</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Myocardial Revascularization</topic><topic>Percutaneous Coronary Intervention</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative period</topic><topic>Risk Factors</topic><topic>Stents</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rudersdorf, Patrick D., MD</creatorcontrib><creatorcontrib>Abolhoda, Amir, MD</creatorcontrib><creatorcontrib>Carey, Joseph S., MD</creatorcontrib><creatorcontrib>Danielsen, Beate, PhD</creatorcontrib><creatorcontrib>Milliken, Jeffrey C., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rudersdorf, Patrick D., MD</au><au>Abolhoda, Amir, MD</au><au>Carey, Joseph S., MD</au><au>Danielsen, Beate, PhD</au><au>Milliken, Jeffrey C., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adverse Events After Coronary Revascularization Procedures in California 2000 to 2010</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2013-08-15</date><risdate>2013</risdate><volume>112</volume><issue>4</issue><spage>483</spage><epage>487</epage><pages>483-487</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Public reporting of coronary artery bypass grafting (CABG) mortality in California was initiated in 2003. Drug-eluting stents were widely introduced in the same year. Adverse events after percutaneous coronary intervention (PCI) and CABG were analyzed to study the impact of these events. Annual California hospital discharge data were collected from 2000 through 2010. In-hospital mortality and hospital readmission for adverse events <1 year were determined for patients undergoing isolated CABG, PCI for acute coronary syndrome (PCI-ACS), and all other PCIs (PCI-noACS). CABG volume peaked in 2000 and subsequently decreased by 58%; PCI volume peaked in 2005 and subsequently decreased by 20%. After 2003, in-hospital mortality and 1-year mortality for CABG decreased whereas mortality after PCI remained unchanged. Event rates for acute myocardial infarction and stroke varied little over the decade; acute myocardial infarction at 1 year was 2.5% to 2.8% (CABG), 4.5% to 5.4% (PCI-ACS), and 4.6% to 5.8% (PCI-noACS); stroke rate was 1.4% to 1.7% (CABG), 1.2% to 1.6% (PCI-ACS), and 1.0% to 1.2% (PCI-noACS). Reintervention for PCI decreased markedly, from 18.8% to 12.8% (PCI-ACS) and 22.5% to 13.3% (PCI-noACS). Multiple adverse cardiovascular and cerebral events rate at 1 year decreased from 10.8% to 9.4% (CABG), 26.5% to 21.2% (PCI-ACS), and 26.8% to 18.4% (PCI-noACS). Excluding reinterventions, multiple adverse cardiovascular and cerebral events rate at 1 year was 8.3% (CABG), 14.6% (PCI-ACS), and 10.1% (PCI-noACS) in 2010. In conclusion, the volume of coronary interventions in California decreased whereas adverse event rates decreased after the introduction of public reporting and drug-eluting stents. Lower procedure volume combined with improved outcomes resulted in an annual decrease of >6,000 adverse events by the end of the decade.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23668638</pmid><doi>10.1016/j.amjcard.2013.04.009</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2013-08, Vol.112 (4), p.483-487 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1418144437 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
| subjects | Adult Aged California - epidemiology Cardiovascular Cardiovascular disease Coronary Artery Bypass Coronary vessels Female Heart attacks Hospital Mortality Hospitals Humans Incidence Male Middle Aged Mortality Myocardial Revascularization Percutaneous Coronary Intervention Postoperative Complications - epidemiology Postoperative period Risk Factors Stents Treatment Outcome |
| title | Adverse Events After Coronary Revascularization Procedures in California 2000 to 2010 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T03%3A30%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adverse%20Events%20After%20Coronary%20Revascularization%20Procedures%20in%C2%A0California%202000%20to%202010&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Rudersdorf,%20Patrick%20D.,%20MD&rft.date=2013-08-15&rft.volume=112&rft.issue=4&rft.spage=483&rft.epage=487&rft.pages=483-487&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2013.04.009&rft_dat=%3Cproquest_cross%3E1418144437%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1415787433&rft_id=info:pmid/23668638&rft_els_id=S000291491300982X&rfr_iscdi=true |